SCHEMBL21687873

SCHEMBL21687873

N#Cc1cc(-c2c(C#N)cccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)cc(-n2c3ccccc3c3cc(C#N)ccc32)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.32
CYP3A4 P08684 4/20 0.32
CYP2D6 P10635 3/20 0.32
LMNA P02545 3/20 0.32
TP53 P04637 2/20 0.32
TSHR P16473 4/20 0.32
ALDH1A1 P00352 5/20 0.31
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
CYP2C19 P33261 2/20 0.31
CLK4 Q9HAZ1 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C9 P11712 1/20 0.31
GRM5 P41594 1/20 0.31
HRH1 P35367 1/20 0.31
HTR6 P50406 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687779 0.95 ALDH1A1 (0.33) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21687689 0.92 KDM4E (0.34) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21688016 0.90 KDM4E (0.34) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21687487 0.89 LMNA (0.35) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21688070 0.87 PTGER4 (0.33) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21687665 0.87 RARG (0.33) LMNAALDH1A1MEN1KMT2AMAPK1
SCHEMBL21688067 0.86 PTGER4 (0.33) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21687904 0.86 KDM4E (0.33) CYP1A2CYP3A4CYP2D6LMNATP53
SCHEMBL21687973 0.85 KDM4E (0.39) LMNATSHRALDH1A1MEN1KMT2A
SCHEMBL21687654 0.85 RXFP1 (0.31) RXFP1KDM4EPTGER4ADORA2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 CYP1A2 1346/4885CYP3A4 1290/4885CYP2D6 2792/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 CYP1A2 1346/4885CYP3A4 1290/4885CYP2D6 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.